VYNE Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11/14/2025 | 851.35 K | $285.20 K | 100.00% | 1.99% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 586.57 K | $199.43 K | -20.36% | 1.37% |
| SHAY CAPITAL LLC | 11/14/2025 | 492.58 K | $165.01 K | 100.00% | 1.15% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 446.41 K | $148.00 K | 1,891.32% | 1.04% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 290.00 K | $97.15 K | 0.00% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 220.79 K | $73.96 K | 100.00% | 0.52% |
| VANGUARD GROUP INC | 11/07/2025 | 190.38 K | $63.78 K | -61.64% | 0.45% |
| JANE STREET GROUP, LLC | 11/14/2025 | 147.12 K | $49.29 K | 17.86% | 0.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 137.12 K | $45.94 K | 2.84% | 0.32% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 106.46 K | $35.66 K | 0.00% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 76.96 K | $25.78 K | 0.00% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 57.76 K | $19.35 K | -0.09% | 0.14% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 56.60 K | $18.96 K | 100.00% | 0.13% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 50.00 K | $16.75 K | 400.00% | 0.12% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 50.00 K | $16.75 K | 100.00% | 0.12% |
| BLACKROCK, INC. | 11/12/2025 | 44.41 K | $14.88 K | 0.00% | 0.10% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 35.92 K | $12.00 K | 166.75% | 0.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 23.11 K | $7.74 K | 0.00% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 18.30 K | $6.00 K | 0.00% | 0.04% |
| STATE STREET CORP | 11/14/2025 | 15.77 K | $5.28 K | 0.00% | 0.04% |
| HARVEST INVESTMENT SERVICES, LLC | 11/17/2025 | 11.06 K | $3.71 K | -78.45% | 0.03% |
| UBS GROUP AG | 11/13/2025 | 5.57 K | $1.87 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 3.60 K | $1.21 K | 28.28% | 0.01% |
| ROYAL BANK OF CANADA | 11/14/2025 | 2.44 K | $1.00 K | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.53 K | $513 | 4.29% | 0.00% |
| MB, LEVIS & ASSOCIATES, LLC | 10/15/2025 | 1.04 K | $349 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 911 | $305 | -73.29% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 146 | $49 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 65 | $22 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 11/14/2025 | 25 | $8 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/13/2025 | 10 | $3 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CENTERPOINT ADVISORS, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VYNE Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of VYNE Therapeutics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 851,353
ACORN CAPITAL ADVISORS, LLC: 586,572
Shay Capital LLC: 492,577
ACADIAN ASSET MANAGEMENT LLC: 446,414
Ikarian Capital, LLC: 290,000
TWO SIGMA INVESTMENTS, LP: 220,788
9.18% of VYNE Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.09 M shares in the last 24 months. This purchase volume represents approximately $1.90 M in transactions.